THC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
THC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tenet Healthcare's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was $3.34. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was $32.53.
Tenet Healthcare's EPS (Diluted) for the three months ended in Dec. 2024 was $3.32. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $32.23.
Tenet Healthcare's EPS without NRI for the three months ended in Dec. 2024 was $3.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 11.90.
During the past 12 months, Tenet Healthcare's average EPS without NRIGrowth Rate was 70.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 18.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 28.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Tenet Healthcare's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was -47.30% per year. And the median was 8.70% per year.
The historical data trend for Tenet Healthcare's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenet Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
EPS (Basic) | Get a 7-Day Free Trial |
![]() |
![]() |
3.80 | 8.55 | 3.84 | 6.01 | 33.02 |
Tenet Healthcare Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
EPS (Basic) | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
2.42 | 21.60 | 2.66 | 4.93 | 3.34 |
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Tenet Healthcare's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as
Basic EPS (A: Dec. 2024 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (3200 | - | 0) | / | 96.904 | |
= | 33.02 |
Tenet Healthcare's Basic EPS for the quarter that ended in Dec. 2024 is calculated as
Basic EPS (Q: Dec. 2024 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (318 | - | 0) | / | 95.101 | |
= | 3.34 |
EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $32.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenet Healthcare (NYSE:THC) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Tenet Healthcare's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
J Robert Kerrey | director | NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036 |
Cecil D Haney | director | C/O GENERAL DYNAMICS CORPORATION, 11011 SUNSET HILLS ROAD, RESTON VA 20190 |
Lisa Y Foo | officer: EVP, Commercial Ops | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
R. Scott Ramsey | officer: Principal Accounting Officer | 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202 |
Richard W Fisher | director | |
Paola M Arbour | officer: EVP, Chief Information Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Saumya Sutaria | officer: Chief Operating Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Meghan Fitzgerald | director | C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511 |
Christopher S. Lynch | director | 8200 JONES BRANCH DRIVE, MCLEAN VA 22102 |
Nadja West | director | 1915 REXFORD ROAD, CHARLOTTE NC 28211 |
Thomas W Arnst | officer: EVP, Chief Admin. Officer & GC | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Richard J Mark | director | 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103 |
Roy Blunt | director | 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235 |
Stephen H Rusckowski | director | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Tammy Romo | director | C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235 |
From GuruFocus
By GuruFocus News • 02-12-2025
By GuruFocus News • 02-19-2025
By Business Wire • 10-29-2024
By GuruFocus News • 10-30-2024
By Business Wire • 02-12-2025
By GuruFocus News • 11-21-2024
By GuruFocus News • 11-04-2024
By GuruFocus News • 10-29-2024
By GuruFocus News • 03-19-2025
By GuruFocus News • 02-13-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.